hotspot -WSS

hotspot

author：focus 2025-08-12 09:09:23 - browse：33753

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for new obesity medications, streamline insurance coverage for the therapies, and demonstrate long-lasting health benefits.

The Select trial, as the study is called, is the first large, randomized trial to test whether long-term treatment with a weight loss drug can meaningfully improve patients’ cardiovascular health. Novo is testing Wegovy, a weekly injection also sold under the brand name Ozempic for type 2 diabetes, against placebo in the five-year study.

The implications are massive, and not just for Novo. Wegovy is part of a class of medicines that target a hormone called GLP-1, which curbs patients’ appetites. Those drugs have demonstrated an ability to help people lose dramatic amounts of weight in clinical trials, but payers, including Medicare, have been slow to reimburse for them without definitive data on their long-term health benefits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： More regulation could be coming for drug ads

WSS

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Ohioans vote in high

CDC overhauls leadership of center that led response to Covid

Maui funeral service workers on devastation of fires: 'I'm in shock'

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

knowledge

hotspot

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

TB outbreak tied to bone grafts underscores testing shortcomings

ChatGPT in medicine: STAT answers readers' burning questions

Judge rejects Trump's counterclaim against E. Jean Carroll

Virginia high school admissions case could be legal follow

CDC overhauls leadership of center that led response to Covid

Wildfire smoke exposes gaps in outdoor worker protections

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Medical records are filled with copy

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Wikipedia

Choosing scientific sides in the fight against Alzheimer's

White House drug shortages task force keeps mum with Congress

Judge rejects Trump's counterclaim against E. Jean Carroll

White House drug shortages task force keeps mum with Congress

Where are patients getting their prescriptions for GLP

Choosing scientific sides in the fight against Alzheimer's

focus

hotspot

hotspot

hotspot